Histopathology image classification: Highlighting the gap between manual analysis and AI automation
| Combination of | |
|---|---|
| Lidocaine | Local anesthetic |
| Epinephrine | Vasoconstrictor |
| Clinical data | |
| Routes of administration | Topical |
| Legal status | |
| Legal status |
|
| Identifiers | |
| CAS Number | |
| CompTox Dashboard (EPA) | |
| (verify) | |
Iontocaine was an anesthetic medication, marketed under the two brand names Numby and Phoresor PM900 by IOMED inc. It is a local anesthetic with vasoconstrictor, administered via iontophoresis through the skin. It can numb up to 10 mm of skin in as little as 10 minutes. It is a 2% lidocaine, 0.01 mg/ml epinephrine solution. It was manufactured by IOMED, Inc.
Iontocaine was approved by the United States Food and Drug Administration on 21 December 1995.[1] It was discontinued by the manufacturer in 2005.[2]
References
- ^ United States Food and Drug Administration, Drug Approval Reports
- ^ United States Food and Drug Administration, August 2005: Additions and Deletions to the Drug Product List. [1]
External links
- IOMED Numby web page from the Internet Archive
- Iontocaine Package Insert from the Internet Archive
- FDA page on iontocaine
